Q1 2020 Holdings
Filed 2020-05-13 | 10 holdings | $7.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $6.6M | 855,437 | 94.3% |
| Autolus Therapeutics Limited(AUTL) | Common | 05280R100 | $238.0K | 39,740 | 3.4% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $45.1K | 3,898,422 | 0.6% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $36.2K | 2,331,534 | 0.5% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $26.1K | 3,370,982 | 0.4% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $15.7K | 1,423,794 | 0.2% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $13.8K | 308,686 | 0.2% |
| MEI Pharma, Inc. | Common | 552798202 | $10.1K | 6,250,000 | 0.1% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $8.8K | 337,291 | 0.1% |
| Sunesis Pharmaceuticals, Inc. | Common | 867328700 | $1.2K | 2,809,912 | 0.0% |